Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 130,257 | -- | 120,136 | 86,501 | 83,306 | 61,826 |
| General And Administrative Expense | 130,257 | -- | 120,136 | 86,501 | 83,306 | 61,826 |
| Other Operating Expenses | 46,092 | -- | 207,590 | 39,121 | 38,402 | 39,767 |
| Operating Expense | 176,349 | -- | 327,726 | 125,622 | 121,708 | 101,593 |
| Operating Income | -176,349 | -- | -327,726 | -125,622 | -121,708 | -101,593 |
| EBIT | -176,349 | -- | -327,726 | -125,622 | -121,708 | -101,593 |
| Other Income Expense | 515,869 | -- | -781,842 | 11,875 | -- | -- |
| Other Non Operating Income Expenses | -- | -- | 10,000 | 11,875 | -- | -- |
| Special Income Charges | 528,288 | -- | -- | -- | 0.00 | -- |
| Gain On Sale Of Security | -12,419 | -- | -- | -- | -- | -- |
| Pretax Income | 339,520 | -- | -1.1M | -113,747 | -121,708 | -101,593 |
| Tax Effect Of Unusual Items | 77,380 | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | 339,520 | -- | -1.1M | -113,747 | -121,708 | -101,593 |
| Net Income From Continuing Operation Net Minority Interest | 339,520 | -- | -1.1M | -113,747 | -121,708 | -101,593 |
| Net Income Including Noncontrolling Interests | 339,520 | -- | -1.1M | -113,747 | -121,708 | -101,593 |
| Net Income Common Stockholders | 339,520 | -- | -1.1M | -113,747 | -121,708 | -101,593 |
| Net Income | 339,520 | -- | -1.1M | -113,747 | -121,708 | -101,593 |
| EBITDA | -176,349 | -- | -327,726 | -125,622 | -121,708 | -101,593 |
| Normalized EBITDA | -692,218 | -- | -327,726 | -125,622 | -121,708 | -101,593 |
| Basic EPS | 0.00 | -- | -- | 0.00 | 0.00 | 0.00 |
| Diluted EPS | 0.00 | -- | -- | 0.00 | 0.00 | 0.00 |
| Basic Average Shares | 111.2M | -- | -- | 98.9M | 97.4M | 97.4M |
| Diluted Average Shares | 111.2M | -- | -- | 98.9M | 97.4M | 97.4M |
| Total Unusual Items | 515,869 | -- | -- | -- | 0.00 | -- |
| Total Unusual Items Excluding Goodwill | 515,869 | -- | -- | -- | 0.00 | -- |
| Tax Rate For Calcs | 0.15 | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -98,969 | -- | -1.1M | -113,747 | -121,708 | -101,593 |
| Diluted NI Availto Com Stockholders | 339,520 | -- | -1.1M | -113,747 | -121,708 | -101,593 |
| Insurance And Claims | 3,842 | -- | 3,790 | 3,790 | 3,750 | 3,609 |
| Net Income Continuous Operations | 339,520 | -- | -1.1M | -113,747 | -121,708 | -101,593 |
| Other Gand A | 113,415 | -- | 116,346 | 82,711 | 79,556 | 58,217 |
| Other Special Charges | -528,288 | -- | -- | -- | -- | -- |
| Salaries And Wages | 13,000 | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 176,349 | -- | 327,726 | 125,622 | 121,708 | 101,593 |
| Total Operating Income As Reported | -176,349 | -- | -327,726 | -125,622 | -121,708 | -101,593 |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 129,639 | -- | 335,200 | 378,260 | 18,105 | 32,484 |
| Cash Cash Equivalents And Short Term Investments | 129,639 | -- | 335,200 | 378,260 | 18,105 | 32,484 |
| Cash Financial | 129,639 | -- | 335,200 | 378,260 | 18,105 | 32,484 |
| Receivables | 14,026 | -- | 18,671 | 46,021 | 13,976 | 11,092 |
| Current Assets | 143,665 | -- | 353,871 | 424,281 | 32,081 | 43,576 |
| Net PPE | 48,612 | -- | 38,607 | 822,711 | 650,619 | 650,619 |
| Investments And Advances | 227,500 | -- | 370,000 | 500,000 | 500,000 | 500,000 |
| Total Non Current Assets | 276,112 | -- | 408,607 | 1.3M | 1.2M | 1.2M |
| Total Assets | 419,777 | -- | 762,478 | 1.7M | 1.2M | 1.2M |
| Accounts Payable | -- | -- | 1.3M | -- | -- | -- |
| Payables | -- | -- | 1.3M | -- | -- | -- |
| Payables And Accrued Expenses | 605,196 | -- | 1.3M | 1.2M | 920,476 | 810,263 |
| Other Current Liabilities | 130,426 | -- | 144,426 | 32,400 | 11,875 | 11,875 |
| Current Liabilities | 735,622 | -- | 1.4M | 1.2M | 932,351 | 822,138 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 735,622 | -- | 1.4M | 1.2M | 932,351 | 822,138 |
| Common Stock | 13.9M | -- | 13.8M | 13.9M | 13.6M | 13.6M |
| Capital Stock | 13.9M | -- | 13.8M | 13.9M | 13.6M | 13.6M |
| Additional Paid In Capital | 2.7M | -- | 2.7M | 2.7M | 2.6M | 2.6M |
| Retained Earnings | -16.9M | -- | -17.1M | -16.0M | -15.9M | -15.8M |
| Common Stock Equity | -315,845 | -- | -684,762 | 524,279 | 250,349 | 372,057 |
| Stockholders Equity | -315,845 | -- | -684,762 | 524,279 | 250,349 | 372,057 |
| Total Equity Gross Minority Interest | -315,845 | -- | -684,762 | 524,279 | 250,349 | 372,057 |
| Total Capitalization | -315,845 | -- | -684,762 | 524,279 | 250,349 | 372,057 |
| Net Tangible Assets | -315,845 | -- | -684,762 | 524,279 | 250,349 | 372,057 |
| Tangible Book Value | -315,845 | -- | -684,762 | 524,279 | 250,349 | 372,057 |
| Working Capital | -591,957 | -- | -1.1M | -798,432 | -900,270 | -778,562 |
| Invested Capital | -315,845 | -- | -684,762 | 524,279 | 250,349 | 372,057 |
| Share Issued | 115.8M | -- | 110.4M | 110.4M | 97.4M | 97.4M |
| Ordinary Shares Number | 115.8M | -- | 110.4M | 110.4M | 97.4M | 97.4M |
| Available For Sale Securities | 227,500 | -- | 370,000 | 500,000 | 500,000 | 500,000 |
| Investmentin Financial Assets | 227,500 | -- | 370,000 | 500,000 | 500,000 | 500,000 |
| Other Receivables | 14,026 | -- | 18,671 | 46,021 | 13,976 | 11,092 |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -222,361 | -128,584 | -11,146 | -58,062 | -14,379 | -152,708 |
| Cash Flow From Continuing Operating Activities | -222,361 | -- | -11,146 | -58,062 | -14,379 | -152,708 |
| Stock Based Compensation | 13,000 | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Change In Working Capital | -59,012 | -- | 316,580 | 67,559 | 107,329 | -51,115 |
| Change In Receivables | 3,029 | -- | 27,350 | -32,045 | 62,758 | -58,379 |
| Change In Payables And Accrued Expense | -62,041 | -- | 289,230 | 99,604 | 44,571 | 7,264 |
| Other Non Cash Items | -- | -- | 120,000 | -- | -- | -- |
| Capital Expenditure | -8,095 | -- | -24,971 | -1,857 | -- | -4,000 |
| Purchase Of PPE | -8,095 | -- | -24,971 | -1,857 | 0.00 | -4,000 |
| Net PPE Purchase And Sale | -8,095 | -- | -24,971 | -1,857 | 0.00 | -4,000 |
| Sale Of Investment | 138,281 | -- | -- | -- | 0.00 | -- |
| Net Investment Purchase And Sale | 138,281 | -- | -- | -- | 0.00 | -- |
| Investing Cash Flow | 130,186 | -- | -24,971 | -1,857 | 0.00 | -4,000 |
| Cash Flow From Continuing Investing Activities | 130,186 | -- | -24,971 | -1,857 | 0.00 | -4,000 |
| Issuance Of Capital Stock | -- | -- | 0.00 | -- | -- | -- |
| Net Common Stock Issuance | -- | -- | 0.00 | -- | -- | -- |
| Financing Cash Flow | -- | -- | -6,943 | -- | -- | -- |
| Cash Flow From Continuing Financing Activities | -- | -- | -6,943 | -- | -- | -- |
| Changes In Cash | -92,175 | -- | -43,060 | 360,155 | -14,379 | -156,708 |
| Beginning Cash Position | 221,814 | -- | 378,260 | 18,105 | 32,484 | 189,192 |
| End Cash Position | 129,639 | -- | 335,200 | 378,260 | 18,105 | 32,484 |
| Free Cash Flow | -230,456 | -- | -36,117 | -59,919 | -14,379 | -156,708 |
| Common Stock Issuance | -- | -- | 0.00 | -- | -- | -- |
| Gain Loss On Investment Securities | 9,469 | -- | -- | -- | -- | -- |
| Net Income From Continuing Operations | 339,520 | -- | -1.1M | -113,746 | -121,708 | -101,593 |
| Net Other Financing Charges | -- | -- | -6,943 | -- | -- | -- |
| Operating Gains Losses | 9,469 | -- | -- | -- | -- | -- |
| Unrealized Gain Loss On Investment Securities | 2,950 | -- | -- | -- | 0.00 | -- |